Catalyst Wire Dossier Catalyst Wire Dossier

TAK-137

· Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TAK-137, covering 2015-02-10 to 2016-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. [Phase 1]

See pricing